Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Dasatinib-blinatumomab for adult Ph+ ALL

Exclusive interview with Prof. Robin Foa on the Phase II study by the GIMEMA study group

Read More

ERIC 2020 Presentations

VJHemOnc was official Media Partner for the ERIC 2020 Virtual Meeting, New Frontiers in CLL Research, which took place on 1-3…

Read More

Real-world effectiveness of IRd in R/R myeloma

Article on the TOURMALINE-MM1 study of ixazomib, lenalidomide and dexamethasone

Read More

Advances in Myeloma Precursor Conditions

Presentations from the virtual meeting held by MMRF & DFCI with VJHemOnc as media partner

Read More

iwMyeloma 2020 Presentations

VJHemOnc was official Media Partner for the 2020 International Workshop on Myeloma which took place on online on September 25th –…

Read More

ISA 2020 Top Picks

VJHemOnc are excited to present the latest updates presented at this year’s virtual International Society of Amyloidosis (ISA) 2020 congress….

Read More

iwNHL 2020 Presentations

VJHemOnc was official Media Partner for the 2020 The International Workshop on Non-Hodgkin Lymphoma which took place on online on September…

Read More

The Texas MPN Workshop

VJHemOnc was official Media Partner for the 1st Texas MPN Workshop which took place on 27-28 August. Below you can find…

Read More

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals